Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease

被引:52
作者
Dolcetti, R
Boiocchi, M
Gloghini, A
Carbone, A
机构
[1] Natl Canc Inst, IRCCS, Ctr Riferimento Oncol, Div Expt Oncol 1, I-33081 Aviano, PN, Italy
[2] Natl Canc Inst, IRCCS, Ctr Riferimento Oncol, Div Pathol, I-33081 Aviano, PN, Italy
关键词
Hodkin's disease; HIV; Epstein-Barr virus; CD40; LMP-1;
D O I
10.1016/S0959-8049(01)00105-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Compared with the cases in the general population, Hodgkin's disease (HD) arising in the HIV setting shows distinctive features in terms of epidemiology. aetiopathogenesis, histopathology and clinical behaviour. Although HD does not represent an AIDS-detining condition. recent evidence consistently indicates that HIV-infected individuals have a significantly increased risk of developing HD. HIV-related HD is characterised by the preponderance of aggressive histological subtypes. advanced stage at presentation, and highly malignant clinical course. Moreover, unlike HD in the general population. the large majority of HIV-related HD cases are pathogenetically linked to Epstein-Barr virus (EBV), with rates of EBV positivity ranging from 80 to 100%. Hodgkin and Reed-Sternberg cells of these cases invariably show a strong expression of the EBV-encoded latent membrane protein-1 (LMP-1), which functions as a constitutively activated tumour necrosis factor (TNF) receptor-like molecule. Usurpation of physiologically relevant pathways by LMP-1 may lead to the simultaneous or sequential activation of signalling pathways involved in the promotion of cell activation. growth, and survival, contributing thus to most of the features of HIV-related HD. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1276 / 1287
页数:12
相关论文
共 135 条
[71]   The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappa B [J].
Izumi, KM ;
Kieff, ED .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12592-12597
[72]   EPSTEIN-BARR VIRUS-ASSOCIATED HODGKINS-DISEASE FOLLOWING RENAL-TRANSPLANTATION [J].
JACCARD, A ;
EMILE, JF ;
METIVIER, F ;
CLAUVEL, JP ;
DAGAY, MF .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (03) :256-257
[73]  
Jaffe ES, 1999, AM J CLIN PATHOL, V111, pS8
[74]   Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy [J].
Kamel, OW ;
Weiss, LM ;
vandeRijn, M ;
Colby, TV ;
Kingma, DW ;
Jaffe, ES .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1279-1287
[75]   EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 IS ESSENTIAL FOR B-LYMPHOCYTE GROWTH TRANSFORMATION [J].
KAYE, KM ;
IZUMI, KM ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :9150-9154
[76]   Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations [J].
Khanim, F ;
Yao, QY ;
Niedobitek, G ;
Sihota, S ;
Rickinson, AB ;
Young, LS .
BLOOD, 1996, 88 (09) :3491-3501
[77]   Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor [J].
Kilger, E ;
Kieser, A ;
Baumann, M ;
Hammerschmidt, W .
EMBO JOURNAL, 1998, 17 (06) :1700-1709
[78]  
Kim SH, 2000, BLOOD, V95, P294
[79]  
KNECHT H, 1993, BLOOD, V82, P2937
[80]  
Koblin BA, 1996, AM J EPIDEMIOL, V144, P916, DOI 10.1093/oxfordjournals.aje.a008861